Hannah Valantine is of CareDx, Inc.. Currently has a direct ownership of 37,461 shares of CDNA, which is worth approximately $845,869. The most recent transaction as insider was on Jun 14, 2024, when has been sold 10,570 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.5K
0% 3M change
39.31% 12M change
Total Value Held $845,869

Hannah Valantine Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2024
BUY
Grant, award, or other acquisition
-
10,570 Added 22.01%
37,461 Common Stock
Jun 16 2023
BUY
Grant, award, or other acquisition
-
18,844 Added 41.2%
26,891 Common Stock
Jan 06 2023
BUY
Grant, award, or other acquisition
-
676 Added 7.75%
8,047 Common Stock
Oct 04 2022
BUY
Grant, award, or other acquisition
-
422 Added 5.42%
7,371 Common Stock
Jul 01 2022
BUY
Grant, award, or other acquisition
-
325 Added 4.47%
6,949 Common Stock
Jun 16 2022
BUY
Grant, award, or other acquisition
-
4,863 Added 42.33%
6,624 Common Stock
Oct 01 2021
BUY
Grant, award, or other acquisition
-
131 Added 6.92%
1,761 Common Stock
Jul 01 2021
BUY
Grant, award, or other acquisition
-
1,630 Added 50.0%
1,630 Common Stock

Also insider at

PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Healthcare
BBIO
BridgeBio Pharma, Inc. Healthcare
HV

Hannah Valantine

South San Francisco, CA

Track Institutional and Insider Activities on CDNA

Follow CareDx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDNA shares.

Notify only if

Insider Trading

Get notified when an Care Dx, Inc. insider buys or sells CDNA shares.

Notify only if

News

Receive news related to CareDx, Inc.

Track Activities on CDNA